• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Voyager contrast injector

Article

Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system

Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system in early April into the U.S. endovascular market. Voyager includes an automated syringe operated by a button-operated device called AngioTouch and a touchscreen display that lets the physician tailor injections at the patient’s side.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.